Amphastar Pharmaceuticals, Inc. (AMPH) Total liabilities 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) total liabilities at each fiscal year-end, per SEC filings.
$840.5MFY2025 · since FY2016: $98.5M → $840.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $840.5M | -0.6% |
| FY2024 | $845.2M | -3.2% |
| FY2023 | $873.5M | +309.5% |
| FY2022 | $213.3M | -5.6% |
| FY2021 | $226.0M | +23.8% |
| FY2020 | $182.5M | +14.5% |
| FY2019 | $159.4M | +6.9% |
| FY2018 | $149.2M | +27.2% |
| FY2017 | $117.3M | +19.1% |
| FY2016 | $98.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice